Clinical Review Report: Dupilumab (Dupixent): (Sanofi-Aventis Canada Inc.) [Internet]
- PMID: 30933448
- Bookshelf ID: NBK539235
Clinical Review Report: Dupilumab (Dupixent): (Sanofi-Aventis Canada Inc.) [Internet]
Excerpt
The objective of this review was to perform a systematic review of the beneficial and harmful effects of dupilumab (Dupixent) for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Copyright © 2018 Canadian Agency for Drugs and Technologies in Health.
Sections
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources